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Background: A genome-wide association study (GWAS) combined with brain imaging as a quantitative trait
analysis revealed that the SNPs near CTXN3-SLC12A2 region were related to forebrain development and stress
response which involved in schizophrenia. In the present study, the SNPs in this region were analyzed for
association with schizophrenia in a Thai population.
Methods: A total of 115 schizophrenia and 173 unrelated normal controls with mean age of 37.87 ± 11.8 and
42.81 ± 6.0 years, respectively, were included in this study. Genotyping was performed using polymerase chain
reaction and high-resolution melting (HRM) analysis. The difference in genotype distribution between patient and
control was assessed by Chi-square test of the SPSS software.
Results: We found a significant association between the GWAS-discovered SNP, rs245178, with the risk of
schizophrenia in the Thai population [P= 0.006, odds ratio for the minor G allele: 0.62(0.46–0.83)]. Additionally,
another potential SNP, rs698172, which was in moderate linkage disequilibrium with rs245178, also showed strong
association with schizophrenia [P= 0.003, odds ratio for minor T allele: 0.61(0.46–0.82)]. This association remained
significant at 5% level after the Bonferroni correction for multiple testing.
Conclusions: This study shows that two SNPs in intergenic of the CTXN3 and SLC12A2 genes, rs245178 and
rs698172, are associated with risk of schizophrenia in Thai population. Further study is required for clarification the
role of genetic variation around these SNPs in expression pattern of the CTXN3 and SLC12A2 genes, which may be
involved in schizophrenia pathogenesis.
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Schizophrenia is characterized by abnormalities in per-
ception, thought, cognition, and expression of reality. It
is clinically described by positive and negative symptoms
[1]. Positive symptoms are psychotic behaviors that are
present in schizophrenia but absent in healthy indivi-
duals, include hallucinations, delusions, and thought dis-
order. Negative symptoms are factors that absent in
schizophrenia patients but are present in healthy persons
[2]. Schizophrenia is one of the most common psychi-
atric disorders and its prevalence is 1% of the worldwide* Correspondence: wasanas@swu.ac.th
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distribution, and reproduction in any mediumpopulation [3]. Twin and family studies suggest that gen-
etic factors play a major role in schizophrenia [4,5].
A variety of genetic studies reported several chromo-
somal regions associated with schizophrenia and related
phenotypes. A quantitative trait locus for schizophrenia
was mapped to a chromosome 5 region in Americans of
European ancestry [6]. A meta-analysis of European eth-
nicity showed that the 5q23.2-q34 region was signifi-
cantly linked with schizophrenia [7].
A genome wide association study (GWAS) in combin-
ation with the data from brain imaging of dorsolateral pre-
frontal cortex (DLPFC) as quantitative trait (QT) analysis
revealed 6 genes/regions that involved in neurodevelop-
ment and response to stress. The first three genes includ-
ing ROBO1-ROBO2, TNIK, and CTXN3-SLC12A2 were
identified by having 2 single-nucleotide polymorphisms
(SNPs) each significant at P< 10−6 for the interactionntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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three genes including POU3F2,TRAF, andGPC1 had a sig-
nificant SNP at <10−6 [8]. Because the GWAS was a
screening method over the whole genome to identify the
SNPs related to risk for schizophrenia and the subject of
previous study mostly Caucasian ethnic group [8]. More-
over, there is no association study of those genes and risk
of schizophrenia in other ethnic groups rather than Euro-
pean ancestry. A replication study with Asian ethnic
groups would help to reinforce the signals obtained in a
European GWAS. Furthermore, the testing of a popula-
tion showing different linkage disequilibrium (LD) struc-
tures may assist in identifying the true causative variant in
the genomic region of interest.
In Thailand, the prevalence of schizophrenia is com-
parable with the worldwide value (approximately 1%).
Genetic variations associated with risks of schizophrenia
have been investigated in opioid-binding protein/cell ad-
hesion molecule (OPCML) gene [9] using GWAS-dis-
covered SNPs of Europeans ancestry [10]. There was
strong association between an intronic SNP of the
OPCML gene (rs1784519) and the risk of schizophrenia
in a Thai population [P= 0.00036, odds ratio for the
minor A allele: 2.11(1.57–2.84)] [9].
This study aims to investigate the association between
SNPs in CTXN3-SLC12A2 region with the risk of schizo-
phrenia in the Thai population. The CTXN3 gene is
located on 5q23 encode CTXN3 (cortexin 3), a brain spe-
cific integral membrane protein highly enriched in cortex.
It is expressed in fetal brain and increases in density peri-
natally. The gene consists of 3 exons and spans an approxi-
mate 9.6 kb region. It has 2 alternative transcript variants
expressed in the brain and kidneys, and encodes an 81-
amino acids protein [11]. This gene is highly conserved in
various species, suggesting that this gene plays important
roles in brain and kidney function. The gene, SLC12A2
(solute carrier family 12, member 2), found in the same re-
gion as CTXN3, encodes a sodium-potassium-chloride
(Na-K-Cl) cotransporter protein which is expressed in
various human tissues, including the brain [12]. SLC12A2
is involved in the regulation of GABA neurotransmission.
Both CTXN3 and SLC12A2 are indicated to play a role in
normal brain function, in addition, the CTXN3-SLC12A2
region is considered as the second most important region
linked to schizophrenia in the meta-analysis [7,8], there-
fore, they may be involved in schizophrenia pathogenesis.
This study, the SNPs in the intergenic ofCTXN3-SLC12A2
region, 3′-UTR and intronic of CTXN3 gene were analyze
for their association with schizophrenia.
Methods
Subjects
A total number of subjects consisted of 115 schizophre-
nia patients (61 males and 54 females) with a mean ageof 37.87 ± 11.8 years and 173 unrelated healthy controls
(110 males and 63 females) with a mean age of
42.81 ± 6.0 years. The patients were diagnosed according
to the Diagnostic and Statistical Manual of Mental Dis-
orders, Fourth Edition (DSM-IV) criteria. The healthy
controls were also psychiatrically screened to confirm
that they did not suffer from a psychiatric disorder. All
patients and healthy controls gave informed consent for
participation in this study, which was approved by the
ethical committee at the Faculty of Medicine, Chiang
Mai University and Faculty of Medicine, Srinakharin-
wirot University.
Genotyping
Genomic DNAs of patient and control were extracted
from whole blood (5 ml) using Flexigene DNA kit (Qia-
gen, German). Genotyping was performed by using
polymerase chain reaction (PCR) and followed by high-
resolution melting analysis (HRM). PCR primers were
designed using LightScanner Primer Design software
(Idaho Technology, Salt Lake City, UT, USA) and the pri-
mer sequences were included in supplement table (avail-
able online). The PCR was carried out using TaKaRa Ex
Taq Hot Start Version (TaKaRa, Tokyo, Japan) with
LCGreen + (Idaho Technology). The high-resolution
melting analysis was performed using a LightScanner
(Idaho Technology, USA). Sequences of primers are pro-
vided in the Additional file 1.
Statistical analysis
The linkage disequilibrium (LD) status of the GWAS-
discovered marker SNPs; rs245178, rs245201 [8], and
nearby SNPs; rs1421746, rs711360, rs698171, rs698172,
rs245314, rs245311, rs245310, rs9285907, rs151849,
rs6874357, rs245199, rs245195, rs245192, rs245191,
rs1579284, rs181746, rs245186, rs6864687, rs151879,
rs245179, rs245181, and rs245183, were determined
using 47 randomly selected schizophrenia patients and
healthy controls. LD analyses were performed using
Haploview software [13]. SNPs with a marked deviation
from Hardy-Weinberg equilibrium (P< 0.01) were
excluded from further analysis. The association analysis
was assessed by using Pearson’s Chi-square test imple-
mented in SPSS program version 11.5 for Window. We
assessed 3 genotype models (additive, dominant, and re-
cessive) in the association analysis. The significance level
of the association test was set at 5% and moreover, we
also applied the Bonferroni correction for the numbers
of SNPs tested. For the SNPs showing significant associ-
ation, mode of inheritance was inferred by using the
method proposed Zintzaras and Santos [14]. The gener-
alized odds ratio of genotypes [15] and odds ratio of the
minor allele of each SNP were calculated. For the allelic
test, we evaluated statistical power by using the G*Power
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were estimated as 2.00(0.37), 1.74(0.51), 1.65(0.57), 1.62
(0.60), and 1.62(0.61), for alleles with frequencies in the
controls of 0.1, 0.2, 0.3, 0.4 and 0.5, respectively. We also
estimated sex and age adjusted-odds ratio of the SNP
genotypes with the aid of multiple logistic regression
analysis. Haplotypes of the SNPs were reconstructed by
using PHASE2.0 [17]. Differences in haplotype frequen-
cies between the patients and the controls were assessed
by using χ2 test.Results
Association study of SNPs and schizophrenia
We first tested the associations between the GWAS-dis-
covered SNPs that located in the intergenic of CTXN3-
SLC12A2 region, 3'-UTR and intronic of CTXN3 gene
with schizophrenia in Thai population. The result of the
association analysis is summarized in Table 1. The SNPs
in intergenic, rs245178, showed significant differences in
the genotype distribution between patients and controls
(P= 0.006, under the dominant model). The odds ratioTable 1 Results of the association analyses
dbSNP ID Type of SNP Genotype frequenci
rs7711139 CTXN3 A/A A/G
intronic Patients 17 45
Controls 13 74
rs248707 CTXN3 C/C C/T
3′UTR Patients 7 40
Controls 8 53
rs1421746 Intergenic C/C C/T
Patients 37 49
Controls 38 71
rs698172 Intergenic C/C C/T
Patients 49 41
Controls 47 81
rs698171 Intergenic G/G G/T
Patients 57 44
Controls 105 63
rs245201 Intergenic A/A A/G
Patients 51 41
Controls 56 82
rs245178 Intergenic A/A A/G
Patients 54 43
Controls 55 83
1MAF: Minor allele frequency.
2P values for the additive model (a), dominant model (d), and recessive model (r) ar
Bonferroni correction for multiple SNP testing.
3Allelic OR (upper) indicates odds ratio and 95% confidence interval of minor allele
genotypes [14].(OR) and 95% confidence intervals (CI) of the minor G
allele were estimated to be 0.62 and 0.46–0.83, respect-
ively. The lower prevalence of the G allele in patients
was consistent with the result of the previous report [8].
In contrast, another GWAS-discovered SNP, rs245201,
did not show significant differences in genotype distribu-
tion in Thai population (P> 0.05).Linkage disequilibrium analysis
The LD status of rs245178 and nearby SNPs in 47 ran-
domly selected Thai individuals was determined and the
result of LD analysis is shown in Figure 1. The LD struc-
ture was generally similar to that of a population with
European ancestry (HapMap CEU, data not shown). The
rs245178 was found in a large LD block spanning 43 kb
in our Thai population. To narrow the region containing
the responsible SNPs, we selected the rs1421746,
rs698171, and rs698172, which were in moderate LD
with the rs245178, and tested for the association with
schizophrenia. The rs698172 showed the strongest asso-
ciation (P= 0.003, under the dominant model) and thees MAF1 P2 Allelic OR3Generalized OR
G/G a 0.139 1.29(0.96–1.74)
52 0.34 d 0.528 1.23(0.84–1.95)
85 0.29 r 0.047
T/T a 0.594 1.24(0.88–1.74)
67 0.24 d 0.325 1.27(0.80–2.00)
111 0.20 r 0.580
T/T a 0.025 0.61(0.46–0.81)
26 0.45 d 0.038 0.58(0.39–0.86)
64 0.57 r 0.015
T/T a 0.012 0.61(0.46–0.82)
21 0.38 d 0.003* 0.58(0.38–0.87)
45 0.49 r 0.167
T/T a 0.028 1.56(1.13–2.16)
11 0.29 d 0.10 1.58(1.01–2.48)
5 0.21 r 0.01
G/G a 0.083 0.81(0.60–1.08)
22 0.37 d 0.052 0.77(0.51–1.15)
30 0.42 r 0.759
G/G a 0.021 0.62(0.46–0.83)
15 0.33 d 0.006* 0.57(0.38–0.86)
34 0.44 r 0.165
e shown. Asterisks indicate tests that were significant at 5% level after the
s. Generalized OR (lower) indicates odds ratio and 95% confidence interval of
Figure 1 Linkage disequilibrium status of the CTXN3-SLC12A2 region in Thai individuals. r2 values calculated from genotype data of 47
Thai are indicated. The haplotype blocks were defined by using the default setting of the Haploview software.
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patients than in controls (OR= 0.61) (Table 1). Sex and
age adjusted- OR and 95% CI of carriers of the each
minor allele were estimated as 0.50 and 0.30–0.84 for
both SNPs. We also tested the rs248707, rs6959787, and
rs7711139, which were located in the CTXN3 gene and
did not show strong LD with the SNPs tested above.
The rs248707 and rs7711139, which possibly had func-
tional consequences for the CTXN3 gene, did not show
a significant association with schizophrenia (P= 0.325
and P= 0.528, respectively). Marked deviation from
Hardy-Weinberg equilibrium was observed for the
rs6959787 (P= 0.004 in the patients; P= 0.0009 in the
controls) and thus, association analysis was not per-
formed for this SNP. Among the seven SNPs tested, the
rs245178 and rs698172 remained significant at 5% level
after the Bonferroni correction for multiple SNP testing
(P< 0.0071). Degree of dominance h for rs245178 and
rs698172 were −0.50 and −0.51, respectively. These
values fell into 0< |h|< 1, supporting that the minor al-
lele of these two SNPs were dominant [14]. LD status of
the 7 SNPs in the patients and in the controls are shown
in Figure 2. Neither D’ nor r2 values showed striking dif-
ferences between the patients and controls.Haplotype analysis
We reconstructed haplotypes of rs245178 and rs698172
and tested the differences in haplotype frequencies be-
tween patients and controls (Table 2). A total of four
haplotypes were observed in the studied population. Fre-
quencies of these haplotypes were significantly different
between the patients and the controls (P= 0.0447).
Moreover, a haplotype consist T allele of rs698172 and
G allele of rs245178 was significantly underrepresented
in patients (in Table 2; Haplotype 2 versus Haplotype 3,
P= 0.005, OR= 0.58).
Discussion
In the present study, a total of four SNPs in CTXN3-
SLC12A2 region—rs245178, rs698172, rs1421746, and
rs698171 were shown to be significantly associated with
a risk of schizophrenia in a Thai population that is con-
sistent with the previous GWAS report [8]. Another
GWAS-discovered SNP, rs245201, showed a marginal
association with schizophrenia (P= 0.052, under the
dominant model). In a population of European ancestry
(HapMap CEU panel), rs245201 was in absolute LD with
rs698172, but this was not the case in our Thai popula-
tion (r2= 0.5). The differences in LD structure would
Figure 2 Pairwise LD status of the 7 SNPs in 115 patients and 173 controls. Upper and lower triangles indicate D’ and r2, respectively. LD
status of each pair of SNPs is color-coded by its strength (see the explanatory notes in the figure).
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Furthermore, the rs698172, which was separated by
45.5 kb from the rs245178, showed the strongest associ-
ation with risk of schizophrenia in the Thai group. The
minor T allele of rs698172 was shown to reduce the risk
of schizophrenia. The haplotype-based association ana-
lysis revealed that the frequency of haplotypes of the
rs698172 T and rs245178 G alleles was significantly lower
in patients (P= 0.005), and the odds ratio was smaller
than those of rs698172 and rs245178. Further verification
is required to determine whether this haplotype effect is
the actual influences susceptibility to schizophrenia. The
associations detected for the rs245178 and rs698172 were
considered to simply reflect LD of these two SNPs. The
rs245178 and rs698172 were located in the intergenic re-
gion between CTXN3 and SLC12A2 genes, and it is stillTable 2 Haplotype analysis
rs698172 rs245178 Patient Control
Haplotype1 T A 0.09(0.02) 0.10(0.02)
Haplotype2 T G 0.29(0.03) 0.39(0.03)
Haplotyep3 C A 0.58(0.03) 0.46(0.03)






*P values in χ2 test are shown.
For each haplotype, relative frequencies and the standard deviation (in
parentheses) are shown.unclear whether functional elements affecting gene func-
tions exist in this region.
CTXN3 protein is a brain-specific integral membrane
protein, highly enriched within the cortex [18]. It shows
43% homology with cortexin (CTXN 1), which is highly
enriched in the cerebral cortex and is probably an inte-
gral membrane protein playing a role in the developing
and adult cerebral cortex [18]. It is expected that
CTXN3 is also a member of the integral membrane pro-
teins and is relevant to the development and function of
the cerebral cortex. Another candidate gene in this re-
gion, SLC12A2, was expressed in various human tissues,
including brain [12]. SLC12A2 was highly expressed in
developing cortical neurons and promotes the accumula-
tion of chloride ion (Cl-) in neurons [19]. Moreover,
SLC12A2 protein facilitates seizure in the developing
brain [19]. The significant associations between SNPs
and risk of schizophrenia suggest potential roles of these
two genes in the pathogenesis of schizophrenia.Conclusions
The present study showed that two SNPs in the
CTXN3-SLC12A2 region, rs245178, and rs698172 are
associated with risk of schizophrenia in Thai popula-
tion. These SNPs were located in intergenic region
with unknown function. Further study, it would be of
interest to identify genetic variation around these SNPs
affecting the expression pattern of the CTXN3 and
SLC12A2 genes and test the association with risk for
schizophrenia.
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